Insmed | INSM - Créances Commerciales

Prix De L'Action
151.00
Variation Quotidienne
-3.81 -2.46%
Mensuellement
4.43%
Annuel
112.59%
Q2 Prévisions
150.58




Créances Commerciales Changement Date
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Cytokinetics USD 1.81M 6.6M 2025-09
DBV Technologies USD 15.97M 279K 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12